JDS Journal of Data Science 1683-86021680-743X1680-743X School of Statistics, Renmin University of China JDS1161A 10.6339/25-JDS1161A Discussion Discussion of “Power Priors for Leveraging Historical Data: Looking Back and Looking Forward”✩ NieLeilei.nie@fda.hhs.gov1 DB IV/OB/OTS/CDER/FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA

Main article: https://doi.org/10.6339/24-JDS1161.

 20254220252314851 2025 The Author(s). Published by the School of Statistics and the Center for Applied Statistics, Renmin University of China.2025 Open access article under the CC BY license. References Chen M-H, Guan Z, Lin M, Sun M (2025). Power priors for leveraging historical data: looking back and looking forward. Journal of Data Science, 23(1): 1–30. https://doi.org/10.6339/24-JDS1161 Chen M-H, Ibrahim JG (2006). The relationship between the power prior and hierarchical models. Bayesian Analysis, 1(3): 551–574. https://doi.org/10.1214/06-BA118 Chu Y, Yuan Y (2018). A Bayesian basket trial design using a calibrated Bayesian hierarchical model. Clinical Trials, 15: 149–158. https://doi.org/10.1177/1740774518755122 FDA (2019). BLA 125370/s-064 and BLA 761043/s-007 Multi-disciplinary Review and Evaluation Benlysta® (belimumab) for Intravenous Infusion in Children 5 to 17 Years of Age with SLE. Freidlin B, Korn EL (2013). Borrowing information across subgroups in phase II trials: Is it useful? Clinical Cancer Research, 19: 1326–1334. https://doi.org/10.1158/1078-0432.CCR-12-1223 Gelman A, Carlin JB, Stern HS, Rubin DB (1995). Bayesian Data Analysis. Chapman and Hall/CRC. Hobbs BP, Carlin BP, Mandrekar SJ, Sargent DJ (2011). Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials. Biometrics, 67: 1047–1056. https://doi.org/10.1111/j.1541-0420.2011.01564.x Ibrahim JG, Chen M-H, Sinha D (2003). On optimality properties of the power prior. Journal of the American Statistical Association, 98: 204–213. https://doi.org/10.1198/016214503388619229 Ibrahim JG, Chen MH, Gwon Y, Chen F (2015). The power prior: Theory and applications. Statistics in Medicine, 34: 3724–3749. https://doi.org/10.1002/sim.6728 Jiang L, Nie L, Yan F, Yuan Y (2021). Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials. Contemporary Clinical Trials, 107: 106460. https://doi.org/10.1016/j.cct.2021.106460 Jiang L, Nie L, Yuan Y (2023). Elastic priors to dynamically borrow information from historical data in clinical trials. Biometrics, 79: 49–60. https://doi.org/10.1111/biom.13551 Neuenschwander B, Branson M, Spiegelhalter DJ (2009). A note on the power prior. Statistics in Medicine, 28: 3562–3566. https://doi.org/10.1002/sim.3722 Schmidli H, Gsteiger S, Roychoudhury S, O’Hagan A, Spiegelhalter D, Neuenschwander B (2014). Robust meta-analytic-predictive priors in clinical trials with historical control information. Biometrics, 70: 1023–1032. https://doi.org/10.1111/biom.12242 Shi W, Chen M-H, Kuo L, Lewis PO (2022). Bayesian concentration ratio and dissonance. Bayesian Analysis, 17: 817–847. https://doi.org/10.1214/21-BA1277 Wang X, Suttner L, Jemielita T, Li X (2022). Propensity score-integrated Bayesian prior approaches for augmented control designs: A simulation study. Journal of Biopharmaceutical Statistics, 32: 170–190. https://doi.org/10.1080/10543406.2021.2011743 Yang P, Zhao Y, Nie L, Vallejo J, Yuan Y (2023). SAM: Self-adapting mixture prior to dynamically borrow information from historical data in clinical trials. Biometrics, 79: 2857–2868. https://doi.org/10.1111/biom.13927 Yuan W, Chen M-H, Zhong J (2021). Flexible conditional borrowing approaches for leveraging historical data in the Bayesian design of superiority trials. Statistics in Biosciences, 14: 197–215. https://doi.org/10.1007/s12561-021-09321-7